REGULATED PRESS RELEASE published on 03/26/2025 at 07:35, 10 months 10 days ago Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros Biophytis annonce le succès d'un placement privé d'environ 2,6 millions d'euros. Augmentation de capital pour accélérer le développement de traitements et soutenir les activités de recherche et de partenariats Biophytis Placement Privé Augmentation De Capital Investisseurs Recherche Médicale
REGULATED PRESS RELEASE published on 03/26/2025 at 07:35, 10 months 10 days ago Biophytis announces the successful completion of a €2,6 million private placement Biophytis successfully completes €2.6M private placement, aiming to accelerate clinical programs and partnerships, strengthen corporate purposes, and extend cash runway Private Placement Biophytis Biotechnology Fundraising Clinical Programs
BRIEF published on 03/24/2025 at 07:35, 10 months 12 days ago Biophytis Reveals New Preclinical Findings on Obesity Treatment Biophytis Obesity Treatment GLP-1 Preclinical Results Muscle Strength
BRIEF published on 03/24/2025 at 07:35, 10 months 12 days ago Biophytis : Nouvelles Avancées dans le Traitement de l'Obésité Biophytis Mobilite BIO101 Obésité GLP-1
REGULATED PRESS RELEASE published on 03/24/2025 at 07:30, 10 months 12 days ago Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients Biophytis Preclinical Study BIO101 Obesity GLP-1
REGULATED PRESS RELEASE published on 03/24/2025 at 07:30, 10 months 12 days ago Biophytis annonce de nouvelles données non cliniques renforçant sa mission de pionnier dans la restauration de la mobilité chez les patients souffrant d’obésité. Biophytis annonce de nouvelles données non cliniques renforçant sa mission de pionnier dans la restauration de la mobilité chez les patients souffrant d'obésité Biophytis Mobilite Obésité Étude Préclinique Force Musculaire
BRIEF published on 03/17/2025 at 07:05, 10 months 19 days ago Biophytis avance dans le traitement de la sarcopénie Biophytis Essais Cliniques Sarcopénie BIO101 Phase III
BRIEF published on 03/17/2025 at 07:05, 10 months 19 days ago Biophytis Publishes Promising Sarcopenia Trial Results Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
REGULATED PRESS RELEASE published on 03/17/2025 at 07:00, 10 months 19 days ago Biophytis révolutionne la sarcopénie Biophytis révolutionne la sarcopénie avec BIO101. Résultats prometteurs de l'étude SARA-INT publiés. Passage à la Phase 3 confirmé. Importante avancée dans le traitement de la sarcopénie Biophytis Traitement Étude Clinique Sarcopénie BIO101
REGULATED PRESS RELEASE published on 03/17/2025 at 07:00, 10 months 19 days ago Biophytis revolutionizes sarcopenia Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety Biophytis Clinical Trial Sarcopenia Phase II SARA-INT
Published on 02/05/2026 at 21:00, 29 minutes ago Kidoz Welcomes CloudX Innovation Driving Fairer Mobile Advertising Auctions
Published on 02/05/2026 at 18:50, 2 hours 39 minutes ago Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 3 hours 54 minutes ago Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 4 hours 49 minutes ago Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 5 hours 44 minutes ago American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 19:27, 2 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 2 hours 43 minutes ago EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 3 hours 20 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 3 hours 34 minutes ago Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 3 hours 49 minutes ago BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 19:15, 2 hours 14 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 2 hours 14 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 2 hours 14 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL